| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.007 |